Today on The Fundamentals is Dr. Maria Castro, the R.C. Schneider collegiate professor of neurosurgery, and a professor of cell and developmental biology at the University of Michigan Medical School. Her research program aims to develop immunotherapies for primary and metastatic brain cancer, studying basic immune biology mechanisms leading to clinical implementation. She has been inducted into the American Association for the Advancement of Sciences, the Latin American Academy of Sciences, and the American Institute for Medical and Biological Engineering College of Fellows. She has won numerous awards for her contributions to basic science and cancer research and is a diversity ambassador for the Cancer Biology Graduate Training Program. You can learn more about Dr. Castro here, and you can follow her @castro2355_mg, the Rogel Cancer Center @UMRogelCancer, the department of neurosurgery @umichneuro, Michigan Neurscience Institute @UM_MNI and the department of cell and developmental biology @UMCDB on X

Join Dr. Deb Berman, assistant dean for admissions, and Carol Teener, director of admissions, along with two current medical students from the University of Michigan Medical School for answers to your questions about getting into medical school and more. The conversation ranges from GPAs and personal statements to the culture and experiences that make Michigan unique.

Four faculty and two staff members from the departments of Anesthesiology, Neurology, Radiology and Surgery, and the Office of Graduate Medical Education (GME), are recipients of GME Awards for 2024

Known as the Health Equity Literature Archive, Chelsea Fisk’s goal was to cultivate empathy and understanding for people from different backgrounds and diverse identities by providing employees with access to diverse literature. The innovative pilot led by clinical researcher Chelsea Fisk served as a form of DEI education that was free to use, self-paced and barrier-free.

The Healthcare Equity Consult Service addresses the concern of bias and discriminations in health care access, delivery, and experience for University of Michigan-Health.

Recently approved by the Food and Drug Administration, Pluvicto is a radionuclide-labelled drug administered to patients showing promising results.

Findings from researchers at the University of Michigan Health Rogel Cancer Center, published in Cancer Discovery, show how a specific nucleotide metabolite called GTP controls responses to radiation and chemotherapy in an unexpected way.

Technology developed at U-M uses sound waves to destroy tissue, providing a new type of cancer therapy

Michigan Medicine has developed a new technique that provides a non-invasive alternative to surgery, chemotherapy and radiation treatments for cancer.

While it's tempting to know what's going on inside your entire body, a clinical perspective piece, written by a radiologist at the University of Michigan, discusses some of the harms of imaging low risk patients, such as overdiagnosis, overtreatment and their related complications

There are 13 U-M graduate medical education programs ranked in the top 10 by Doximity.

Research from the University of Michigan now confirms this: a study found choosing to withhold IV contrast from certain types of abdominal CT scans can decrease the accuracy of the scan by about 30%.

Radiologists play a large role in many tumor diagnoses, but rarely get the recognition for it.

Radiation, used to treat half of all cancer patients, can be measured during treatment for the first time with precise 3D imaging developed at the University of Michigan.